Trends in Pricing and Out-of-Pocket Spending on Entecavir Among Commercially Insured Patients, 2014-2018

• DOI: 10.1001/jamanetworkopen.2021.44521
• Publication Date: 2022-01-21T16:36:14Z
• Authors: Jonathan D. Alpern; Heesoo Joo; Ben Link; Antonio Ciaccia; William M. Stauffer; Nathan C. Bahr; Thomas M. Leventhal
• Keywords: Financing, Personal; Guanine; Fees and Charges; Research Letter; Deductibles and Coinsurance; Humans; Health Expenditures; Antiviral Agents; United States

This cross-sectional study of health claims from patients with private insurance examines trends in the cost of entecavir prescribed for chronic hepatitis B treatment.